Nanomaterials In Personalized Medicine Global Market Report 2025
상품코드:1855930
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
맞춤 의료용 나노물질 시장 규모는 최근 급속도로 확대되고 있습니다. 2024년 3,514억 1,000만 달러에서 2025년에는 3,929억 7,000만 달러에 달하고, CAGR 11.8%로 확대될 전망입니다. 실적기간 내 성장은 약물전달에서의 나노기술 채택 증가, 표적 치료에 대한 수요 증가, 맞춤 의료의 이점에 대한 의식 증가, 바이오마커 확인 연구의 확대, 만성 질환의 유병률 증가와 관련이 있습니다.
맞춤 의료용 나노물질 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 연평균 복합 성장률(CAGR) 11.5%로 6,063억 9,000만 달러로 성장할 전망입니다. 예측기간 동안 예측되는 성장의 원동력은 정밀의료에 대한 수요 증가, 나노의료에 대한 정부자금 증가, 생명공학기업과 제약기업 간의 협력관계 확대, 고도 진단 툴의 채용 증가, 환자에 특화된 치료에 대한 주목 증가입니다. 예측 기간 동안의 1차 동향에는 나노입자 설계의 기술적 진보, 나노기반 약물 제제 개발, 표적 전달 시스템의 혁신, 맞춤 치료의 R&D 투자 증가, 의료용 하이브리드 나노물질의 진보 등이 있습니다.
맞춤 의료에 대한 수요 증가는 향후 수년간 맞춤 의료용 나노물질 시장의 확대를 촉진할 것으로 예측됩니다. 맞춤 의료는 치료 결과와 치료의 질을 높이기 위해 유전적 요인, 환경 요인 및 생활 습관 요인을 기반으로 개별 환자의 치료법을 사용자 정의하는 것입니다. 이 수요는 유전자 돌연변이의 정확한 동정과 개인별 맞춤 치료법의 개발을 가능하게 하는 유전체 기술의 진보에 의해 증가하고 있습니다. 나노물질은 치료의 효능과 안전성을 향상시키는 환자 고유의 표적 치료를 가능하게 함으로써 맞춤 의료에서 중요한 역할을 합니다. 나노물질은 드래그, 유전자, RNA의 정확한 전달을 촉진하고, 부작용을 최소화하고, 치료 효과를 극대화합니다. 예를 들어 2024년 2월 미국을 기반으로 하는 비영리 단체인 맞춤의료연합(Personalized Medicine Coalition)은 미국 식품의약국이 2023년에 26개의 개별화 신약을 승인했다고 보고했습니다(2022년 승인은 12개). 그러므로 맞춤 의료에 대한 수요 증가는 맞춤 의료용 나노물질 시장의 성장을 가속하고 있습니다.
이 시장의 주요 기업은 변화하는 규제 요건에 적응하면서 임상 응용을 가속화하고, 치료 응용을 확대하여 시장 출시 시간을 단축하기 위해 전략적 파트너십 형성에 주력하고 있습니다. 전략적 제휴에는 혁신을 가속화하고 맞춤 의료의 기회를 확대하기 위해 기업 간 또는 기관 간 전문 지식과 자원을 결합하는 것이 포함됩니다. 예를 들어, 2025년 5월 캐나다에 본사를 둔 생명공학 기업인 Acuitas Therapeutics Inc.는 미국의 유전체학 솔루션 제공업체인 Integrated DNA Technologies Inc.와 협력하여 회사의 지질 나노입자 플랫폼을 이용한 맞춤 CRISPR 유전자 편집 요법을 제공하기 시작했습니다. 이 치료법은 표적을 정확하게 좁힌 CRISPR 페이로드, 맞춤 복용량, 신속한 제형화를 채택하여 희귀 유전질환을 가진 한 유아를 치료했습니다. 이 진보는 고도로 맞춤 치료를 촉진하고 치료 정밀도와 환자 예후를 개선하는 한편, 확장 가능한 제조, 엄격한 규제에 적응, 극소량 생산과 관련된 과제를 제시합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 맞춤 의료용 나노물질 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 맞춤 의료용 나노물질 시장 : 성장률 분석
세계의 맞춤 의료용 나노물질 시장 실적 : 규모와 성장(2019-2024년)
세계의 맞춤 의료용 나노물질 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 맞춤 의료용 나노물질 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 맞춤 의료용 나노물질 시장 : 나노물질 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
탄소 나노물질
금속 나노입자
고분자 나노물질
나노구조재료
실리카 나노입자
세계의 맞춤 의료용 나노물질 시장 : 제제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
나노입자
나노현탁액
나노에멀젼
나노결정
표적 전달을 위한 나노제형
세계의 맞춤 의료용 나노물질 시장 : 이용 기술별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
나노가공기술
바이오컨쥬게이션법
표면 개질 기술
분자 이미징 기술
나노기술 기반 스크리닝법
세계의 맞춤 의료용 나노물질 시장 : 용도 분야별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
약물전달 시스템
진단과 이미징
치료
재생 의료
백신
세계의 맞춤 의료용 나노물질 시장 : 최종사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 및 클리닉
연구기관
제약기업
생명공학 기업
학술기관
세계의 맞춤 의료용 나노물질 시장 세분화 : 탄소 나노물질 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
풀러렌
탄소나노튜브
그래핀
카본 도트
세계의 맞춤 의료용 나노물질 시장 세분화 : 금속 나노입자 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
금 나노입자
은 나노입자
산화철 나노입자
구리 나노입자
세계의 맞춤 의료용 나노물질 시장 세분화 : 고분자 나노물질 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
덴드리머
미셀
고분자 나노입자
하이드로겔
세계의 맞춤 의료용 나노물질 시장 세분화 : 나노구조재료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
양자점
나노와이어
나노시트
나노로드
세계의 맞춤 의료용 나노물질 시장 세분화 : 실리카 나노입자 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
메조포러스 실리카 나노입자
콜로이달 실리카 나노입자
다공성 실리카 나노 입자
기능성 실리카 나노입자
제7장 지역별/국가별 분석
세계의 맞춤 의료용 나노물질 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 맞춤 의료용 나노물질 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
맞춤 의료용 나노물질 시장 : 경쟁 구도
맞춤 의료용 나노물질 시장 : 기업 프로파일
Pfizer & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
BASF SE : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
The Bristol-Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Abbott Laboratories
Merck KGaA Darmstadt Germany
Evonik Industries AG
Eisai Co. Ltd.
TUV Rheinland AG
OCSiAl SA
American Elements Inc.
Cour Pharmaceuticals Inc.
Nanocomposix Inc.
NoPo Nanotechnologies Private Limited
Matexcel Biotech Inc.
OncoNano Medicine Inc.
Molecular Rebar Design Inc.
Cello Therapeutics Inc.
Apurano Pharmaceuticals GmbH
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
맞춤 의료용 나노물질 시장(2029년) : 새로운 기회를 제공하는 국가
맞춤 의료용 나노물질 시장(2029년) : 새로운 기회를 제공하는 부문
맞춤 의료용 나노물질 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
CSM
영문 목차
영문목차
Nanomaterials in personalized medicine are highly engineered substances at the nanoscale, designed to interact with biological systems precisely and in a controlled manner. They enable healthcare interventions to be tailored to an individual's specific genetic, molecular, or physiological characteristics. These nanomaterials enhance therapeutic effectiveness, minimize potential side effects, and improve overall patient outcomes by supporting targeted, controlled, and individualized medical interventions.
The primary types of nanomaterials in personalized medicine include carbon-based nanomaterials, metallic nanoparticles, polymeric nanomaterials, nanostructured materials, and silica nanoparticles. Carbon-based nanomaterials consist of tiny structures primarily made of carbon, such as graphene, carbon nanotubes, and fullerenes. They are available in various formulations, including nanoparticles, nanosuspensions, nanoemulsions, nanocrystals, and nanoformulations for targeted delivery. Technologies used include nanofabrication techniques, bioconjugation methods, surface modification techniques, molecular imaging techniques, and nanotechnology-based screening methods. Applications include drug delivery systems, diagnostics and imaging, therapeutics, regenerative medicine, and vaccines. End users include hospitals, clinics, research laboratories, pharmaceutical companies, biotechnology firms, and academic institutions.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The nanomaterials in personalized medicine market research report is one of a series of new reports from The Business Research Company that provides nanomaterials in personalized medicine market statistics, including nanomaterials in personalized medicine industry global market size, regional shares, competitors with a nanomaterials in personalized medicine market share, detailed nanomaterials in personalized medicine market segments, market trends and opportunities, and any further data you may need to thrive in the nanomaterials in personalized medicine industry. This nanomaterials in personalized medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The nanomaterials in personalized medicine market size has grown rapidly in recent years. It will grow from $351.41 billion in 2024 to $392.97 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth during the historic period is linked to increasing adoption of nanotechnology in drug delivery, rising demand for targeted therapies, growing awareness of the benefits of personalized medicine, expansion of research in biomarker identification, and higher prevalence of chronic diseases.
The nanomaterials in personalized medicine market size is expected to see rapid growth in the next few years. It will grow to $606.39 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth projected for the forecast period is driven by growing demand for precision medicine, increasing government funding for nanomedicine, expansion of collaborations between biotech and pharmaceutical companies, rising adoption of advanced diagnostic tools, and greater focus on patient-specific treatments. Primary trends during the forecast period include technological advancements in nanoparticle design, developments in nano-based drug formulations, innovations in targeted delivery systems, increased investment in research and development of personalized therapies, and progress in hybrid nanomaterials for medical applications.
The growing demand for personalized medicine is expected to drive the expansion of the nanomaterials in personalized medicine market in the coming years. Personalized medicine involves customizing treatments for individual patients based on their genetic, environmental, and lifestyle factors to enhance treatment outcomes and quality of care. This demand is increasing due to progress in genomic technologies, which allow for accurate identification of genetic variations and the development of targeted therapies for each person. Nanomaterials play a crucial role in personalized medicine by enabling targeted, patient-specific therapies that enhance the effectiveness and safety of treatments. They facilitate precise delivery of drugs, genes, or RNA, minimizing side effects and maximizing therapeutic results. For example, in February 2024, the Personalized Medicine Coalition, a nonprofit organization based in the US, reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, compared to 12 approvals in 2022. Hence, the rising demand for personalized medicine is fueling growth in the nanomaterials in personalized medicine market.
Leading companies in this market are concentrating on forming strategic partnerships to speed up clinical translation, broaden therapeutic applications, and reduce time-to-market while adapting to changing regulatory requirements. Strategic collaborations involve combining expertise and resources between companies or institutions to accelerate innovation and expand opportunities in personalized medicine. For instance, in May 2025, Acuitas Therapeutics Inc., a biotechnology firm based in Canada, partnered with Integrated DNA Technologies Inc., a US genomics solutions provider, to launch a personalized CRISPR gene-editing therapy delivery using their lipid nanoparticle platform. This therapy treated a single infant with a rare genetic disorder, employing precisely targeted CRISPR payloads, customized dosing, and rapid formulation. This advancement promotes highly individualized treatments, improving therapeutic precision and patient outcomes, while presenting challenges related to scalable manufacturing, stringent regulatory adaptation, and very low-volume production.
In June 2023, Bayer AG, a pharmaceutical and biotechnology company headquartered in Germany, teamed up with Acuitas Therapeutics Inc. to utilize its lipid nanoparticle delivery technology. This collaboration aims to advance Bayer's in vivo gene editing and protein replacement programs by leveraging Acuitas' lipid nanoparticle platform to deliver RNA efficiently and selectively, especially to the liver. Acuitas Therapeutics Inc. is a Canadian biotechnology company specializing in lipid nanoparticle delivery systems, which are critical nanomaterials for personalized medicine.
Major players in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TUV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.
North America was the largest region in the nanomaterials in personalized medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nanomaterials in personalized medicine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the nanomaterials in personalized medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The nanomaterials in personalized medicine market consists of revenues earned by entities by providing services such as gene and RNA therapy formulation, personalized diagnostic solutions, nanocarrier design and manufacturing, clinical translation support, and custom nanoparticle-based treatment development. The market value includes the value of related goods sold by the service provider or included within the service offering. The nanomaterials in personalized medicine market also includes sales of targeted gene delivery kits, nanoparticle-based diagnostic kits, nanocarrier-enabled vaccine formulations, nano-biosensors, and lab-scale nanofabrication equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Nanomaterials In Personalized Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on nanomaterials in personalized medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for nanomaterials in personalized medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nanomaterials in personalized medicine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type Of Nanomaterials: Carbon-Based Nanomaterials; Metallic Nanoparticles; Polymeric Nanomaterials; Nanostructured Materials; Silica Nanoparticles
2) By Formulation Type: Nanoparticles; Nanosuspensions; Nanoemulsions; Nanocrystals; Nanoformulations For Targeted Delivery
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Nanomaterials In Personalized Medicine Market Characteristics
3. Nanomaterials In Personalized Medicine Market Trends And Strategies
4. Nanomaterials In Personalized Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Nanomaterials In Personalized Medicine Growth Analysis And Strategic Analysis Framework
5.1. Global Nanomaterials In Personalized Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Nanomaterials In Personalized Medicine Market Growth Rate Analysis
5.4. Global Nanomaterials In Personalized Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Nanomaterials In Personalized Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Nanomaterials In Personalized Medicine Total Addressable Market (TAM)
6. Nanomaterials In Personalized Medicine Market Segmentation
6.1. Global Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Carbon-Based Nanomaterials
Metallic Nanoparticles
Polymeric Nanomaterials
Nanostructured Materials
Silica Nanoparticles
6.2. Global Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nanoparticles
Nanosuspensions
Nanoemulsions
Nanocrystals
Nanoformulations For Targeted Delivery
6.3. Global Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nanofabrication Techniques
Bioconjugation Methods
Surface Modification Techniques
Molecular Imaging Techniques
Nanotechnology-Based Screening Methods
6.4. Global Nanomaterials In Personalized Medicine Market, Segmentation By Application Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Delivery Systems
Diagnostics And Imaging
Therapeutics
Regenerative Medicine
Vaccines
6.5. Global Nanomaterials In Personalized Medicine Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Research Laboratories
Pharmaceutical Companies
Biotechnology Firms
Academic Institutions
6.6. Global Nanomaterials In Personalized Medicine Market, Sub-Segmentation Of Carbon-Based Nanomaterials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fullerenes
Carbon Nanotubes
Graphene
Carbon Dots
6.7. Global Nanomaterials In Personalized Medicine Market, Sub-Segmentation Of Metallic Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gold Nanoparticles
Silver Nanoparticles
Iron Oxide Nanoparticles
Copper Nanoparticles
6.8. Global Nanomaterials In Personalized Medicine Market, Sub-Segmentation Of Polymeric Nanomaterials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dendrimers
Micelles
Polymeric Nanoparticles
Hydrogels
6.9. Global Nanomaterials In Personalized Medicine Market, Sub-Segmentation Of Nanostructured Materials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Quantum Dots
Nanowires
Nanosheets
Nanorods
6.10. Global Nanomaterials In Personalized Medicine Market, Sub-Segmentation Of Silica Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mesoporous Silica Nanoparticles
Colloidal Silica Nanoparticles
Porous Silica Nanoparticles
Functionalized Silica Nanoparticles
7. Nanomaterials In Personalized Medicine Market Regional And Country Analysis
7.1. Global Nanomaterials In Personalized Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Nanomaterials In Personalized Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Nanomaterials In Personalized Medicine Market
8.1. Asia-Pacific Nanomaterials In Personalized Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Nanomaterials In Personalized Medicine Market
9.1. China Nanomaterials In Personalized Medicine Market Overview
9.2. China Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Nanomaterials In Personalized Medicine Market
10.1. India Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Nanomaterials In Personalized Medicine Market
11.1. Japan Nanomaterials In Personalized Medicine Market Overview
11.2. Japan Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Nanomaterials In Personalized Medicine Market
12.1. Australia Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Nanomaterials In Personalized Medicine Market
13.1. Indonesia Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Nanomaterials In Personalized Medicine Market
14.1. South Korea Nanomaterials In Personalized Medicine Market Overview
14.2. South Korea Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Nanomaterials In Personalized Medicine Market
15.1. Western Europe Nanomaterials In Personalized Medicine Market Overview
15.2. Western Europe Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Nanomaterials In Personalized Medicine Market
16.1. UK Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Nanomaterials In Personalized Medicine Market
17.1. Germany Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Nanomaterials In Personalized Medicine Market
18.1. France Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Nanomaterials In Personalized Medicine Market
19.1. Italy Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Nanomaterials In Personalized Medicine Market
20.1. Spain Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Nanomaterials In Personalized Medicine Market
21.1. Eastern Europe Nanomaterials In Personalized Medicine Market Overview
21.2. Eastern Europe Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Nanomaterials In Personalized Medicine Market
22.1. Russia Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Nanomaterials In Personalized Medicine Market
23.1. North America Nanomaterials In Personalized Medicine Market Overview
23.2. North America Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Nanomaterials In Personalized Medicine Market
24.1. USA Nanomaterials In Personalized Medicine Market Overview
24.2. USA Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Nanomaterials In Personalized Medicine Market
25.1. Canada Nanomaterials In Personalized Medicine Market Overview
25.2. Canada Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Nanomaterials In Personalized Medicine Market
26.1. South America Nanomaterials In Personalized Medicine Market Overview
26.2. South America Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Nanomaterials In Personalized Medicine Market
27.1. Brazil Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Nanomaterials In Personalized Medicine Market
28.1. Middle East Nanomaterials In Personalized Medicine Market Overview
28.2. Middle East Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Nanomaterials In Personalized Medicine Market
29.1. Africa Nanomaterials In Personalized Medicine Market Overview
29.2. Africa Nanomaterials In Personalized Medicine Market, Segmentation By Type Of Nanomaterials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Nanomaterials In Personalized Medicine Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Nanomaterials In Personalized Medicine Market, Segmentation By Technology Utilized, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Nanomaterials In Personalized Medicine Market Competitive Landscape And Company Profiles
30.1. Nanomaterials In Personalized Medicine Market Competitive Landscape
30.2. Nanomaterials In Personalized Medicine Market Company Profiles
30.2.1. Pfizer & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. BASF SE Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. The Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Nanomaterials In Personalized Medicine Market Other Major And Innovative Companies
31.1. Abbott Laboratories
31.2. Merck KGaA Darmstadt Germany
31.3. Evonik Industries AG
31.4. Eisai Co. Ltd.
31.5. TUV Rheinland AG
31.6. OCSiAl S.A.
31.7. American Elements Inc.
31.8. Cour Pharmaceuticals Inc.
31.9. Nanocomposix Inc.
31.10. NoPo Nanotechnologies Private Limited
31.11. Matexcel Biotech Inc.
31.12. OncoNano Medicine Inc.
31.13. Molecular Rebar Design Inc.
31.14. Cello Therapeutics Inc.
31.15. Apurano Pharmaceuticals GmbH
32. Global Nanomaterials In Personalized Medicine Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Nanomaterials In Personalized Medicine Market
34. Recent Developments In The Nanomaterials In Personalized Medicine Market
35. Nanomaterials In Personalized Medicine Market High Potential Countries, Segments and Strategies
35.1 Nanomaterials In Personalized Medicine Market In 2029 - Countries Offering Most New Opportunities
35.2 Nanomaterials In Personalized Medicine Market In 2029 - Segments Offering Most New Opportunities
35.3 Nanomaterials In Personalized Medicine Market In 2029 - Growth Strategies
